You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Chloride 0.15% In Sodium Chloride 0.45% patents expire, and what generic alternatives are available?

Potassium Chloride 0.15% In Sodium Chloride 0.45% is a drug marketed by Baxter Hlthcare and Fresenius Kabi Usa and is included in two NDAs.

The generic ingredient in POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%?
  • What are the global sales for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%?
Summary for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%
Drug patent expirations by year for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%
Pharmacology for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%

US Patents and Regulatory Information for POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648-005 Nov 26, 2002 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% potassium chloride; sodium chloride INJECTABLE;INJECTION 212347-001 Sep 17, 2020 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.